{"database": "openregs", "table": "lobbying_activities", "rows": [[3802509, "1f2e39f3-44fd-4fbe-a61e-6033d00004e3", "Q1", "THE PETRIZZO GROUP, INC.", 305932, "AKEBIA THERAPEUTICS, INC.", "AKEBIA THERAPEUTICS, INC.", 2026, "first_quarter", "MMM", "Provided legislative advocacy specific to the payment of innovative drugs, such as phosphate binders and anemia management drugs in the Medicare End-Stage Renal Dialysis Prospective Payment System (ESRD PPS).", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2026-04-05T21:31:37-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "client_name_normalized", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3802509"], "units": {}, "query_ms": 0.3210339928045869, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}